Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1984 1
1985 1
1987 1
1988 3
1989 2
1990 1
1992 1
1997 1
1998 1
1999 1
2000 4
2001 4
2002 2
2003 4
2004 9
2005 6
2006 7
2007 10
2008 21
2009 14
2010 17
2011 21
2012 27
2013 19
2014 14
2015 16
2016 25
2017 14
2018 29
2019 26
2020 31
2021 35
2022 32
2023 23
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.
Davies M, Færch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, Rosenstock J, Shimomura I, Viljoen A, Wadden TA, Lingvay I; STEP 2 Study Group. Davies M, et al. Among authors: viljoen a. Lancet. 2021 Mar 13;397(10278):971-984. doi: 10.1016/S0140-6736(21)00213-0. Epub 2021 Mar 2. Lancet. 2021. PMID: 33667417 Clinical Trial.
A comprehensive scientific overview of Garcinia cambogia.
Semwal RB, Semwal DK, Vermaak I, Viljoen A. Semwal RB, et al. Among authors: viljoen a. Fitoterapia. 2015 Apr;102:134-48. doi: 10.1016/j.fitote.2015.02.012. Epub 2015 Feb 27. Fitoterapia. 2015. PMID: 25732350 Review.
HEART UK consensus statement on Lipoprotein(a): A call to action.
Cegla J, Neely RDG, France M, Ferns G, Byrne CD, Halcox J, Datta D, Capps N, Shoulders C, Qureshi N, Rees A, Main L, Cramb R, Viljoen A, Payne J, Soran H; HEART UK Medical, Scientific and Research Committee. Cegla J, et al. Among authors: viljoen a. Atherosclerosis. 2019 Dec;291:62-70. doi: 10.1016/j.atherosclerosis.2019.10.011. Epub 2019 Oct 14. Atherosclerosis. 2019. PMID: 31704552 Free article. Review.
Renal stones.
Viljoen A, Chaudhry R, Bycroft J. Viljoen A, et al. Ann Clin Biochem. 2019 Jan;56(1):15-27. doi: 10.1177/0004563218781672. Epub 2018 Jun 13. Ann Clin Biochem. 2019. PMID: 29792045 Review.
Erratum.
Liu S, Li J, Zhang Y, Liu N, Viljoen A, Mostert D, Zuo C, Hu C, Bi F, Gao H, Sheng O, Deng G, Yang Q, Dong T, Dou T, Yi G, Ma LJ, Li C. Liu S, et al. Among authors: viljoen a. New Phytol. 2020 Dec;228(6):2004. doi: 10.1111/nph.16718. Epub 2020 Jul 9. New Phytol. 2020. PMID: 33459356 Free PMC article. No abstract available.
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.
Lingvay I, Catarig AM, Frias JP, Kumar H, Lausvig NL, le Roux CW, Thielke D, Viljoen A, McCrimmon RJ. Lingvay I, et al. Among authors: viljoen a. Lancet Diabetes Endocrinol. 2019 Nov;7(11):834-844. doi: 10.1016/S2213-8587(19)30311-0. Epub 2019 Sep 17. Lancet Diabetes Endocrinol. 2019. PMID: 31540867 Clinical Trial.
393 results